Literature DB >> 30074224

Association of Serotonin Receptors with Attention Deficit Hyperactivity Disorder: A Systematic Review and Meta-analysis.

Yu-Wei Hou1, Ping Xiong2, Xue Gu1, Xin Huang1, Min Wang1, Jing Wu3.   

Abstract

Attention deficit hyperactivity disorder (ADHD) is one of the most common mental disorders in childhood, with a high heritability about 60% to 90%. Serotonin is a monoamine neurotransmitter. Numerous studies have reported the association between the serotonin receptor family (5-HTR) gene polymorphisms and ADHD, but the results are still controversial. In this study, we conducted a meta-analysis of the association between 5-HTR1B, 5-HTR2A, and 5-HTR2C genetic variants and ADHD. The results showed that the 861G allele of 5-HTR1B SNP rs6296 could significantly increase the risk of ADHD (C)R=1.09, 95% CI: 1.01-1.18); the 5-HTR2C gene rs518147 (OR=1.69, 95% CI: 1.38-2.07) and rs3813929 (OR = 1.57, 95% CI: 1.25-1.97) were all associated with the risk of ADHD. In addition, we also carried on a casecontrol study to explore the relevance between potential candidate genes 5-HTR1A, 5-HTR1E, 5-HTR3A and ADHD. The results indicated that 5-HTR1A rs6295 genotype (CC+CG vs. GG OR=2.00, 95% CI: 1.23-3.27) and allele (OR=1.77, 95% CI: 1.16-2.72) models were statistically significantly different between case group and control group. This study is the first comprehensive exploration and summary of the association between serotonin receptor family genetic variations and ADHD, and it also provides more evidence for the etiology of ADHD.

Entities:  

Keywords:  association study; attention deficit hyperactivity disorder; genetic variations; meta-analysis; serotonin receptor

Mesh:

Substances:

Year:  2018        PMID: 30074224     DOI: 10.1007/s11596-018-1912-3

Source DB:  PubMed          Journal:  Curr Med Sci        ISSN: 2523-899X


  137 in total

1.  The pharmacology of impulsive behaviour in rats VII: the effects of serotonergic agonists and antagonists on responding under a discrimination task using unreliable visual stimuli.

Authors:  J L Evenden
Journal:  Psychopharmacology (Berl)       Date:  1999-10       Impact factor: 4.530

Review 2.  [Serotonergic control of prefrontal cortex].

Authors:  M V Puig; P Celada; F Artigas
Journal:  Rev Neurol       Date:  2004 Sep 16-30       Impact factor: 0.870

3.  Activation of the brain 5-HT2C receptors causes hypolocomotion without anxiogenic-like cardiovascular adjustments in mice.

Authors:  Oliver Stiedl; Ilga Misane; Melanie Koch; Tommy Pattij; Michael Meyer; Sven Ove Ogren
Journal:  Neuropharmacology       Date:  2006-12-04       Impact factor: 5.250

Review 4.  Genetics of attention-deficit/hyperactivity disorder: current findings and future directions.

Authors:  Glaucia Chiyoko Akutagava-Martins; Angelica Salatino-Oliveira; Christian Costa Kieling; Luis Augusto Rohde; Mara Helena Hutz
Journal:  Expert Rev Neurother       Date:  2013-04       Impact factor: 4.618

Review 5.  Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system.

Authors:  Małgorzata Filip; Michael Bader
Journal:  Pharmacol Rep       Date:  2009 Sep-Oct       Impact factor: 3.024

Review 6.  Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions.

Authors:  Mark J Millan; Philippe Marin; Joëel Bockaert; Clotilde Mannoury la Cour
Journal:  Trends Pharmacol Sci       Date:  2008-09       Impact factor: 14.819

7.  Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status.

Authors:  S Mannuzza; R G Klein; A Bessler; P Malloy; M LaPadula
Journal:  Arch Gen Psychiatry       Date:  1993-07

Review 8.  Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD).

Authors:  Robert D Oades
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

9.  Inhibitory effects of osemozotan, a serotonin 1A-receptor agonist, on methamphetamine-induced c-Fos expression in prefrontal cortical neurons.

Authors:  Rie Tsuchida; Masahiro Kubo; Norihito Shintani; Michikazu Abe; Katalin Köves; Kazuki Uetsuki; Mariko Kuroda; Hitoshi Hashimoto; Akemichi Baba
Journal:  Biol Pharm Bull       Date:  2009-04       Impact factor: 2.233

10.  Serotonin 2A Receptor Gene Polymorphism in Korean Children with Attention-Deficit/Hyperactivity Disorder.

Authors:  Soo-Churl Cho; Jung-Woo Son; Boong-Nyun Kim; Jae-Won Kim; Hee-Jeong Yoo; Jun-Won Hwang; Dae-Yeon Cho; Un-Sun Chung; Tae-Won Park
Journal:  Psychiatry Investig       Date:  2012-09-06       Impact factor: 2.505

View more
  9 in total

Review 1.  Systematic review of mitochondrial genetic variation in attention-deficit/hyperactivity disorder.

Authors:  Stavroula V Giannoulis; Daniel Müller; James L Kennedy; Vanessa Gonçalves
Journal:  Eur Child Adolesc Psychiatry       Date:  2022-07-07       Impact factor: 4.785

Review 2.  The Roles of Serotonin in Neuropsychiatric Disorders.

Authors:  Mahsa Pourhamzeh; Fahimeh Ghasemi Moravej; Mehrnoosh Arabi; Elahe Shahriari; Soraya Mehrabi; Richard Ward; Reza Ahadi; Mohammad Taghi Joghataei
Journal:  Cell Mol Neurobiol       Date:  2021-03-02       Impact factor: 5.046

3.  REVERSE phenotyping-Can the phenotype following constitutive Tph2 gene inactivation in mice be transferred to children and adolescents with and without adhd?

Authors:  Atae Akhrif; Arunima Roy; Katharina Peters; Klaus-Peter Lesch; Marcel Romanos; Angelika Schmitt-Böhrer; Susanne Neufang
Journal:  Brain Behav       Date:  2021-02-01       Impact factor: 2.708

Review 4.  Efficacy and Safety of Melatonin Treatment in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder-A Review of the Literature.

Authors:  Beata Rzepka-Migut; Justyna Paprocka
Journal:  Brain Sci       Date:  2020-04-07

Review 5.  Gestational Factors throughout Fetal Neurodevelopment: The Serotonin Link.

Authors:  Sabrina I Hanswijk; Marcia Spoelder; Ling Shan; Michel M M Verheij; Otto G Muilwijk; Weizhuo Li; Chunqing Liu; Sharon M Kolk; Judith R Homberg
Journal:  Int J Mol Sci       Date:  2020-08-14       Impact factor: 5.923

6.  Comprehensive exploration of the genetic contribution of the dopaminergic and serotonergic pathways to psychiatric disorders.

Authors:  Judit Cabana-Domínguez; Bàrbara Torrico; Andreas Reif; Noèlia Fernàndez-Castillo; Bru Cormand
Journal:  Transl Psychiatry       Date:  2022-01-10       Impact factor: 6.222

7.  HTR1A Inhibits the Progression of Triple-Negative Breast Cancer via TGF-β Canonical and Noncanonical Pathways.

Authors:  Qiqi Liu; Hefen Sun; Yang Liu; Xuan Li; Baojin Xu; Liangdong Li; Wei Jin
Journal:  Adv Sci (Weinh)       Date:  2022-02-24       Impact factor: 17.521

Review 8.  Attention-deficit/hyperactive disorder updates.

Authors:  Miriam Kessi; Haolin Duan; Juan Xiong; Baiyu Chen; Fang He; Lifen Yang; Yanli Ma; Olumuyiwa A Bamgbade; Jing Peng; Fei Yin
Journal:  Front Mol Neurosci       Date:  2022-09-21       Impact factor: 6.261

9.  Acute Tryptophan Depletion Moja-De: A Method to Study Central Nervous Serotonin Function in Children and Adolescents.

Authors:  Richard M Stewart; Janice W Y Wong; Simone Mahfouda; Hugo A E Morandini; Pradeep Rao; Kevin C Runions; Florian D Zepf
Journal:  Front Psychiatry       Date:  2020-03-06       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.